**Question:** Shortest acting non-depolarising neuromuscular blocker

**Core Concept:** Non-depolarising neuromuscular blocking agents (NMBAs) are a class of medications that temporarily inhibit muscle contraction by blocking the transmission of electrical signals at the neuromuscular junction. They are classified into short, intermediate, and long acting groups based on their duration of action.

**Why the Correct Answer is Right:** The correct answer, **D:** succinylcholine, is a short-acting non-depolarising NMBA. Succinylcholine acts by binding to the acetylcholine receptor at the neuromuscular junction, preventing the binding of acetylcholine and thus blocking muscle contraction. Its short duration of action allows for rapid muscle relaxation during surgery, followed by a rapid return of muscle function after administration of a reversal agent like neostigmine.

**Why Each Wrong Option is Incorrect:**

A. **Option A (Orphenadrine):** Orphenadrine is a centrally acting muscle relaxant, blocking the release of acetylcholine at the neuromuscular junction. However, it is not a NMBA but a centrally acting muscle relaxant, making it an incorrect choice.

B. **Option B (Pancuronium):** Pancuronium is a long-acting non-depolarising NMBA, which is longer acting than succinylcholine but not as short as succinylcholine.

C. **Option C (Mivacurium):** Mivacurium is another long-acting non-depolarising NMBA, similar to pancuronium. It is longer acting than succinylcholine but not as short as succinylcholine.

**Clinical Pearl:** Succinylcholine is primarily used during elective surgeries to facilitate intubation and maintain a stable operative field. Its short duration of action ensures a rapid return of muscle function post-surgery, allowing for easy reversal with neostigmine. However, it should not be used in patients with myasthenia gravis, known as the cholinesterase inhibitors, or in those with known hyperkalemia, as it may exacerbate the condition. Succinylcholine should not be used in patients with myasthenia gravis, as it worsens the condition by increasing acetylcholine levels at the neuromuscular junction.

**Correct Answer Explanation:** Succinylcholine is the shortest acting NMBA due to its highly selective action on the neuromuscular junction without affecting the central nervous system. It is particularly useful in emergency situations where rapid muscle relaxation is required, such as airway management during cardiopulmonary resuscitation or in patients with difficult intubation conditions.